Oman
-
Venus Remedies launches flagship R&D drug Elores in Oman
The company is targeting the $237-million antibiotic market in the GCC region, out of which 35 per cent accounts for…
Read More » -
Oman to fast approve Indian pharma products registered by US FDA, UKMHRA, EMA
Strategies and opportunities were highlighted for Indian companies in Oman in this sector The 10th Session of the India-Oman Joint…
Read More »